申请人:SmithKline Corporation
公开号:US04197297A1
公开(公告)日:1980-04-08
6-Halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines whose structures have a hydroxy group substituted on the 1-phenyl ring have potent and specific antihypertensive activity by means of their peripheral dopaminergic effect. The lead compound of the series is 6-chloro-7,8-dihydroxy-(p-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepi ne methane sulfonate.
结构上在1-苯基环上有一个羟基取代的6-卤-7,8-二羟基-1-苯基-2,3,4,5-四氢-1H-3-苯并环辛烷类化合物具有强效和特异的降压活性,通过其外周多巴胺能作用实现。该系列的首要化合物是6-氯-7,8-二羟基-(对羟基苯基)-2,3,4,5-四氢-1H-3-苯并环辛烷甲磺酸盐。